Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.
Identifieur interne : 003F81 ( Ncbi/Merge ); précédent : 003F80; suivant : 003F82Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.
Auteurs : Y. Meng [Royaume-Uni] ; S. Ward ; K. Cooper ; S. Harnan ; L. WyldSource :
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [ 1532-2157 ] ; 2011.
Descripteurs français
- KwdFr :
- Aisselle, Analyse coût-bénéfice, Biopsie de noeud lymphatique sentinelle, Femelle, Humains, Imagerie par résonance magnétique (économie), Métastase lymphatique, Noeuds lymphatiques (anatomopathologie), Noeuds lymphatiques (imagerie diagnostique), Radiographie, Tomographie par émission de positons (économie), Tumeurs du sein (anatomopathologie), Tumeurs du sein (diagnostic), Tumeurs du sein (économie).
- MESH :
- anatomopathologie : Noeuds lymphatiques, Tumeurs du sein.
- diagnostic : Tumeurs du sein.
- imagerie diagnostique : Noeuds lymphatiques.
- économie : Imagerie par résonance magnétique, Tomographie par émission de positons, Tumeurs du sein.
- Aisselle, Analyse coût-bénéfice, Biopsie de noeud lymphatique sentinelle, Femelle, Humains, Métastase lymphatique, Radiographie.
English descriptors
- KwdEn :
- Axilla, Breast Neoplasms (diagnosis), Breast Neoplasms (economics), Breast Neoplasms (pathology), Cost-Benefit Analysis, Female, Humans, Lymph Nodes (diagnostic imaging), Lymph Nodes (pathology), Lymphatic Metastasis, Magnetic Resonance Imaging (economics), Positron-Emission Tomography (economics), Radiography, Sentinel Lymph Node Biopsy.
- MESH :
- diagnosis : Breast Neoplasms.
- diagnostic imaging : Lymph Nodes.
- economics : Breast Neoplasms, Magnetic Resonance Imaging, Positron-Emission Tomography.
- pathology : Breast Neoplasms, Lymph Nodes.
- Axilla, Cost-Benefit Analysis, Female, Humans, Lymphatic Metastasis, Radiography, Sentinel Lymph Node Biopsy.
Abstract
UK guidelines for breast cancer recommend axillary nodal assessment via surgical methods such as sentinel lymph node biopsy (SLNB). However, these procedures are associated with adverse effects such as lymphoedema. Magnetic resonance imaging (MRI) and positron emission tomography (PET) are non-invasive imaging techniques. The aim of this study is to evaluate the cost-effectiveness of MRI and PET compared with SLNB for assessment of axillary lymph node metastases in newly-diagnosed early stage breast cancer patients in the UK.
DOI: 10.1016/j.ejso.2010.10.001
PubMed: 21115232
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002833
- to stream PubMed, to step Curation: 002833
- to stream PubMed, to step Checkpoint: 002833
Links to Exploration step
pubmed:21115232Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.</title><author><name sortKey="Meng, Y" sort="Meng, Y" uniqKey="Meng Y" first="Y" last="Meng">Y. Meng</name><affiliation wicri:level="1"><nlm:affiliation>School of Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, UK. y.meng@sheffield.ac.uk</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield</wicri:regionArea><wicri:noRegion>Sheffield</wicri:noRegion></affiliation></author><author><name sortKey="Ward, S" sort="Ward, S" uniqKey="Ward S" first="S" last="Ward">S. Ward</name></author><author><name sortKey="Cooper, K" sort="Cooper, K" uniqKey="Cooper K" first="K" last="Cooper">K. Cooper</name></author><author><name sortKey="Harnan, S" sort="Harnan, S" uniqKey="Harnan S" first="S" last="Harnan">S. Harnan</name></author><author><name sortKey="Wyld, L" sort="Wyld, L" uniqKey="Wyld L" first="L" last="Wyld">L. Wyld</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21115232</idno><idno type="pmid">21115232</idno><idno type="doi">10.1016/j.ejso.2010.10.001</idno><idno type="wicri:Area/PubMed/Corpus">002833</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002833</idno><idno type="wicri:Area/PubMed/Curation">002833</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002833</idno><idno type="wicri:Area/PubMed/Checkpoint">002833</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002833</idno><idno type="wicri:Area/Ncbi/Merge">003F81</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.</title><author><name sortKey="Meng, Y" sort="Meng, Y" uniqKey="Meng Y" first="Y" last="Meng">Y. Meng</name><affiliation wicri:level="1"><nlm:affiliation>School of Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, UK. y.meng@sheffield.ac.uk</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>School of Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield</wicri:regionArea><wicri:noRegion>Sheffield</wicri:noRegion></affiliation></author><author><name sortKey="Ward, S" sort="Ward, S" uniqKey="Ward S" first="S" last="Ward">S. Ward</name></author><author><name sortKey="Cooper, K" sort="Cooper, K" uniqKey="Cooper K" first="K" last="Cooper">K. Cooper</name></author><author><name sortKey="Harnan, S" sort="Harnan, S" uniqKey="Harnan S" first="S" last="Harnan">S. Harnan</name></author><author><name sortKey="Wyld, L" sort="Wyld, L" uniqKey="Wyld L" first="L" last="Wyld">L. Wyld</name></author></analytic><series><title level="j">European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</title><idno type="eISSN">1532-2157</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Axilla</term><term>Breast Neoplasms (diagnosis)</term><term>Breast Neoplasms (economics)</term><term>Breast Neoplasms (pathology)</term><term>Cost-Benefit Analysis</term><term>Female</term><term>Humans</term><term>Lymph Nodes (diagnostic imaging)</term><term>Lymph Nodes (pathology)</term><term>Lymphatic Metastasis</term><term>Magnetic Resonance Imaging (economics)</term><term>Positron-Emission Tomography (economics)</term><term>Radiography</term><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Aisselle</term><term>Analyse coût-bénéfice</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Femelle</term><term>Humains</term><term>Imagerie par résonance magnétique (économie)</term><term>Métastase lymphatique</term><term>Noeuds lymphatiques (anatomopathologie)</term><term>Noeuds lymphatiques (imagerie diagnostique)</term><term>Radiographie</term><term>Tomographie par émission de positons (économie)</term><term>Tumeurs du sein (anatomopathologie)</term><term>Tumeurs du sein (diagnostic)</term><term>Tumeurs du sein (économie)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Noeuds lymphatiques</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lymph Nodes</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Breast Neoplasms</term><term>Magnetic Resonance Imaging</term><term>Positron-Emission Tomography</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Noeuds lymphatiques</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term><term>Lymph Nodes</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Imagerie par résonance magnétique</term><term>Tomographie par émission de positons</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Axilla</term><term>Cost-Benefit Analysis</term><term>Female</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Radiography</term><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Aisselle</term><term>Analyse coût-bénéfice</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Femelle</term><term>Humains</term><term>Métastase lymphatique</term><term>Radiographie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">UK guidelines for breast cancer recommend axillary nodal assessment via surgical methods such as sentinel lymph node biopsy (SLNB). However, these procedures are associated with adverse effects such as lymphoedema. Magnetic resonance imaging (MRI) and positron emission tomography (PET) are non-invasive imaging techniques. The aim of this study is to evaluate the cost-effectiveness of MRI and PET compared with SLNB for assessment of axillary lymph node metastases in newly-diagnosed early stage breast cancer patients in the UK.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21115232</PMID><DateCreated><Year>2010</Year><Month>12</Month><Day>17</Day></DateCreated><DateCompleted><Year>2011</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2157</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>1</Issue><PubDate><Year>2011</Year><Month>Jan</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.</ArticleTitle><Pagination><MedlinePgn>40-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2010.10.001</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">UK guidelines for breast cancer recommend axillary nodal assessment via surgical methods such as sentinel lymph node biopsy (SLNB). However, these procedures are associated with adverse effects such as lymphoedema. Magnetic resonance imaging (MRI) and positron emission tomography (PET) are non-invasive imaging techniques. The aim of this study is to evaluate the cost-effectiveness of MRI and PET compared with SLNB for assessment of axillary lymph node metastases in newly-diagnosed early stage breast cancer patients in the UK.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An individual patient discrete-event simulation model was developed in SIMUL8(®) to estimate the lifetime costs and benefits of replacing SLNB with MRI or PET, or adding MRI or PET before SLNB. Effectiveness outcomes were derived from a recent systematic review; patient utilities and resource use data were sourced from the literature.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Based on our analysis the baseline SLNB strategy is dominated by the strategies of replacing SLNB with either MRI or PET. The strategy of replacing SLNB with MRI has the highest total quality-adjusted life years (QALYs) and lowest total costs. However, clinical evidence for MRI is based on a limited number of small studies and replacing SLNB with MRI or PET leads to more false-positive and false-negative cases. The strategy of adding MRI before SLNB is cost-effective, but subject to greater uncertainty.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on this analysis the most cost-effective strategy is to replace SLNB with MRI. However, further large studies using up-to-date techniques are required to obtain more accurate data on the sensitivity and specificity of MRI.</AbstractText><CopyrightInformation>Copyright © 2010 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, UK. y.meng@sheffield.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Harnan</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wyld</LastName><ForeName>L</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="Y">Lymph Nodes</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="Y">Positron-Emission Tomography</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021701" MajorTopicYN="Y">Sentinel Lymph Node Biopsy</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>05</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2010</Year><Month>09</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21115232</ArticleId><ArticleId IdType="pii">S0748-7983(10)00523-8</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2010.10.001</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><noCountry><name sortKey="Cooper, K" sort="Cooper, K" uniqKey="Cooper K" first="K" last="Cooper">K. Cooper</name><name sortKey="Harnan, S" sort="Harnan, S" uniqKey="Harnan S" first="S" last="Harnan">S. Harnan</name><name sortKey="Ward, S" sort="Ward, S" uniqKey="Ward S" first="S" last="Ward">S. Ward</name><name sortKey="Wyld, L" sort="Wyld, L" uniqKey="Wyld L" first="L" last="Wyld">L. Wyld</name></noCountry><country name="Royaume-Uni"><noRegion><name sortKey="Meng, Y" sort="Meng, Y" uniqKey="Meng Y" first="Y" last="Meng">Y. Meng</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F81 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003F81 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:21115232
|texte= Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:21115232" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |